Carl D Francis prend les rênes du groupe de technologies médicales axé sur le renversement du diabète, de la stéatohépatite non-alcoolique (SHNA) et de l’obésité LONDRES, 07 févr. 2023 (GLOBE NEWSWIRE) — Keyron, le groupe de technologies médicales axé sur le renversement du diabète de type 2, de la stéatohépatite non-alcoolique (SHNA) et de l’obésité […]
Continue ReadingA single-injection antiviral treatment for newly infected COVID-19 patients reduced the risk of hospitalization by half in a large-scale clinical trial, a study published Wednesday said.Stanford University professor Jeffrey Glenn, co-author of the stud…
Continue ReadingLast November, Northeastern University student Andre Neto Caetano watched the live, late-night launch of NASA’s Artemis 1 from Kennedy Space Center in Florida on a cellphone placed on top of a piano in the lobby of the hotel where he was staying in Cal…
Continue Reading